Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Apogee Therapeutics has raised $1.3B in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
Apogee Therapeutics's investors include RA Capital Management, Blackstone Life Sciences, Wellington Management, Perceptive Advisors, OrbiMed.
Apogee Therapeutics is headquartered in San Francisco, United States.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Apogee Therapeutics is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apogee Therapeutics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/apogee-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Apogee Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/apogee-therapeutics
{{cite web |title=Apogee Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apogee-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated